TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner

The global increase in autoimmunity, together with the emerging autoimmune-related side effects of cancer immunotherapy, have furthered a need for understanding of immune tolerance and activation. Systemic lupus erythematosus (SLE) is the archetypical autoimmune disease, affecting multiple organs, and tissues. Studying SLE creates knowledge relevant not just for autoimmunity, but the immune system in general. Murine models and patient studies have provided increasing evidence for the innate immune toll like receptor-7 (TLR7) in disease initiation and progression. Here, we demonstrated that the kinase activity of the TLR7-downstream signaling molecule, interleukin-1 receptor associated kinase 4 (IRAK4), is essential for mild and severe autoimmune traits of the Sle1 and Sle1-TLR7 transgenic (Sle1Tg7) murine models, respectively. Elimination of IRAK4 signaling prevented all pathological traits associated with murine lupus, including splenomegaly with leukocyte expansion, detectable circulating antinuclear antibodies and glomerulonephritis, in both Sle1 and Sle1Tg7 mice. The expansion of germinal center B cells and increased effector memory T cell phenotypes that are typical of lupus-prone strains, were also prevented with IRAK4 kinase elimination. Analysis of renal leukocyte infiltrates confirmed our earlier findings of an expanded conventional dendritic cell (cDC) within the kidneys of nephritic mice, and this was prevented with IRAK4 kinase elimination. Analysis of TLR7 at the protein level revealed that the expression in immune cells is dependent on the TLR7-transgene itself and/or autoimmune disease factors in a cell-specific manner. Increased TLR7 protein expression in renal macrophages and cDCs correlated with disease parameters such as blood urea nitrogen (BUN) levels and the frequency of leukocytes infiltrating the kidney. These findings suggest that controlling the level of TLR7 or downstream signaling within myeloid populations may prevent chronic inflammation and severe nephritis.

[1]  W. McElroy,et al.  Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018) , 2019, Expert opinion on therapeutic patents.

[2]  L. Rönnblom,et al.  Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor , 2018, Arthritis Research & Therapy.

[3]  J. E. Mejía,et al.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation , 2018, Seminars in Immunopathology.

[4]  B. Au,et al.  Toll‐Like Receptor 9 Deficiency Breaks Tolerance to RNA‐Associated Antigens and Up‐Regulates Toll‐Like Receptor 7 Protein in Sle1 Mice , 2018, Arthritis & rheumatology.

[5]  V. Rao,et al.  Interleukin-1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling , 2018, The Journal of Biological Chemistry.

[6]  A. Canivet,et al.  TLR7 escapes X chromosome inactivation in immune cells , 2018, Science Immunology.

[7]  V. Rao,et al.  IRAK4 kinase activity controls Toll-like receptor–induced inflammation through the transcription factor IRF5 in primary human monocytes , 2017, The Journal of Biological Chemistry.

[8]  K. Elkon,et al.  TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA , 2017, The Journal of experimental medicine.

[9]  A. Medvedev,et al.  Deficiency in IRAK4 activity attenuates manifestations of murine Lupus , 2017, European journal of immunology.

[10]  K. McIntyre,et al.  Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity , 2017, The Journal of Immunology.

[11]  P. Cohen,et al.  Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1 , 2016, The Journal of Immunology.

[12]  J. Harley,et al.  Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. , 2016, Journal of autoimmunity.

[13]  Richard W. Martin,et al.  Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus , 2016, The Journal of Immunology.

[14]  E. Latz,et al.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus , 2016, The Journal of Immunology.

[15]  Y. H. Lee,et al.  Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update , 2016, Lupus.

[16]  H. Choi,et al.  Maintenance of autoantibody production in pristane-induced murine lupus , 2015, Arthritis Research & Therapy.

[17]  L. Staudt,et al.  Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy , 2015, The Journal of experimental medicine.

[18]  P. Gaffney,et al.  X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome , 2015, Arthritis & rheumatology.

[19]  J. Connolly,et al.  RNA sensing by conventional dendritic cells is central to the development of lupus nephritis , 2015, Proceedings of the National Academy of Sciences.

[20]  Shwetank,et al.  B Cell–Intrinsic CD84 and Ly108 Maintain Germinal Center B Cell Tolerance , 2015, The Journal of Immunology.

[21]  S. Akira,et al.  B Cell–Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers , 2014, The Journal of Immunology.

[22]  K. Horikawa,et al.  Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation , 2014, Front. Immunol..

[23]  G. Barton,et al.  Trafficking of endosomal Toll-like receptors. , 2014, Trends in cell biology.

[24]  C. Alpers,et al.  Opposing Impact of B Cell–Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation , 2014, The Journal of Immunology.

[25]  V. V. Singh,et al.  Distinct Autoantibody Profiles in Systemic Lupus Erythematosus Patients are Selectively Associated with TLR7 and TLR9 Upregulation , 2013, Journal of Clinical Immunology.

[26]  P. Gregersen,et al.  MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus , 2013, PLoS genetics.

[27]  J. Connolly,et al.  B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus–Prone Mice , 2012, The Journal of Immunology.

[28]  P. Gaffney,et al.  Sex chromosome aneuploidies among men with systemic lupus erythematosus. , 2012, Journal of autoimmunity.

[29]  Sarah E. Ewald,et al.  Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation. , 2011, Immunity.

[30]  P. Cohen,et al.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity , 2011, The Journal of experimental medicine.

[31]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[32]  A. Kawasaki,et al.  TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study , 2011, Arthritis Research & Therapy.

[33]  J. Connolly,et al.  Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[34]  T. Mak,et al.  Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. , 2011, Arthritis and rheumatism.

[35]  F. Arnett,et al.  Association of a functional IRF7 variant with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[36]  C. Mohan,et al.  Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities , 2010, Mediators of inflammation.

[37]  R. Cantor,et al.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.

[38]  L. Orozco,et al.  Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population , 2010, Annals of the rheumatic diseases.

[39]  S. Akira,et al.  Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. , 2010, Journal of autoimmunity.

[40]  J. Shupe,et al.  TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus , 2010, The Journal of Immunology.

[41]  T. Mayadas,et al.  Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury , 2009, Circulation.

[42]  J. Harley,et al.  Recent insights into the genetic basis of systemic lupus erythematosus , 2009, Genes and Immunity.

[43]  N. Walker,et al.  IRAK-4 Inhibitors for Inflammation , 2009, Current topics in medicinal chemistry.

[44]  B. Beutler,et al.  Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases , 2009, Immunological reviews.

[45]  J. Casanova,et al.  The Kinase Activity of IL-1 Receptor-associated Kinase 4 Is Required for Interleukin-1 Receptor/Toll-like Receptor-induced TAK1-dependent NFκB Activation* , 2008, Journal of Biological Chemistry.

[46]  S. Oshima,et al.  ABIN-1 is a Ubiquitin Sensor that Restricts Cell Death and Sustains Embryonic Development , 2008, Nature.

[47]  J. Harley,et al.  Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.

[48]  S. Akira,et al.  Evidence for Genes in Addition to Tlr7 in the Yaa Translocation Linked with Acceleration of Systemic Lupus Erythematosus1 , 2008, The Journal of Immunology.

[49]  John E. Connolly,et al.  Yaa autoimmune phenotypes are conferred by overexpression of TLR7 , 2008, European journal of immunology.

[50]  John E. Connolly,et al.  Systemic IFN‐α drives kidney nephritis in B6.Sle123 mice , 2008, European journal of immunology.

[51]  A. Syvänen,et al.  A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 , 2008, Human molecular genetics.

[52]  A. Komatsuda,et al.  Up‐regulated expression of Toll‐like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus , 2008, Clinical and experimental immunology.

[53]  A. Arnold,et al.  A role for sex chromosome complement in the female bias in autoimmune disease , 2008, The Journal of experimental medicine.

[54]  S. Frank,et al.  Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans , 2008, Genes and Immunity.

[55]  Xiaoxia Li.  IRAK4 in TLR/IL‐1R signaling: Possible clinical applications , 2008, European journal of immunology.

[56]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[57]  J. Ward,et al.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. , 2007, Immunity.

[58]  B. Livingston,et al.  Negative regulation of TLR9‐mediated IFN‐α induction by a small‐molecule, synthetic TLR7 ligand , 2007 .

[59]  A. Marshak‐Rothstein.  Toll-like receptors in systemic autoimmune disease , 2006, Nature Reviews Immunology.

[60]  S. Akira,et al.  Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. , 2006, Immunity.

[61]  Quanzhen Li,et al.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Satterthwaite,et al.  Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication , 2006, Science.

[63]  C. Mohan,et al.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. , 2005, The Journal of clinical investigation.

[64]  A. Pertsemlidis,et al.  Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. , 2004, Immunity.

[65]  C. Mirtsos,et al.  The Role of Interleukin 1 Receptor-associated Kinase-4 (IRAK-4) Kinase Activity in IRAK-4-mediated Signaling* , 2004, Journal of Biological Chemistry.

[66]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.

[68]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[69]  Roland M. Martin,et al.  The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. , 1998, Journal of immunological methods.

[70]  B. Croker,et al.  Functional dissection of systemic lupus erythematosus using congenic mouse strains. , 1997, Journal of immunology.

[71]  L. Marshall.  Systemic lupus erythematosus , 2016, Nature Reviews Disease Primers.

[72]  S. Oshima,et al.  ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development , 2009, Nature.

[73]  E. Wakeland,et al.  Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. , 2006, Advances in immunology.